Vendor Intelligence Report: Heman Peptide HM

Published 3 Jul 2026. 25-page investigative report on who is behind Heman Peptide HM: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Across 65 Finnrick lab tests, Heman Peptide HM has 55 pass / 10 fail and an overall pass rate of 85%, with GHK-Cu strongest, Retatrutide batch-dependent, and Tirzepatide weakest. The report ties…